<html>
	<head>
		<title>genentech <gene.o> in imaging drug venture</title>
		<meta name="keywords" content="places usa">
</head>
<body>
	<h3>privately-held neorx corp said it has entered into an exclusive agreement with genentech inc for the development of an injectable diagnostic to image blood clots.     it said it genentech will be responsible for marketing, and neorx will receive royalties based on sales.  the product will use a proprietary neorx method of attaching the radioisotope technetium-99m to genentech's blood clot dissolving drug tissue plasminogen activator, or activase.  reuter &#3;</h3>
</body>
</html>